ai is the key to unlocking the power of biological data
The quality and quantity of data is often what determines the effectiveness of treatment, and therefore, the onset, severity and fatality of disease. Healthcare data holds the key to improved outcomes and reduced costs, however, without intelligent curation, and clinically effective AI, this potential can not be fully realised.
To understand disease patterns and develop life-changing solutions, we are starting at birth. Capturing critical healthcare data from day one, enabling us to develop a full data picture for life.
THE WORLD’S FIRST NEONATAL AI DATA-TOOL
Decisions made in the first hour after birth shape a babies health for life, yet, newborns are complete unknowns. With no available biological data, it’s almost impossible for doctors to deliver preventative and personalised treatment.
The first AI data-tool on our platform is a neonatal Lung Maturity Test (LMT). Clinically proven to predict Respiratory Distress Syndrome (RDS) with high sensitivity in two clinical trials, LMT will help prevent this leading cause of morbidity and mortality in premature babies.
Unique and proprietary patient data from thousands of newborns collected and curated by Clinical AI platform. AI led analysis of these data will enabled us to identify unique disease biomarkers.
PARTNER DATA INTEGRATION
By pulling data from different partners, our Clinical AI Platform delivers real world evidence, faster routes to market, trained and relevant AI models, accelerated drug development and improved clinical trials.
The website or its third-party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. View our Cookies Policy
